Mega menu

Home
Product regulation
Product regulation

Understand your obligations and access industry Guidance and other information about the products we regulate.
Safety and shortages
Safety and shortages

Access information about product recalls, shortages and other alerts, and learn how we manage safety.
Resources and guidance
Resources and guidance

Get information to help you understand our work, regulations and industry obligations.
Business services
Business services

Access our systems to submit applications, manage forms, make payments and communicate securely.

Generic Health Pty Ltd

Regulatory activities for this sponsor.

- LinkedIn
- (Twitter)
- Facebook
- Email

Loading...

Type

ARTG (171)
Cancellation by sponsor (129)
Prescription medicine registration (10)
Cancellation or suspension (7)
Australian Public Assessment Report (AusPAR) (1)
Listed medicine compliance report (1)
Prescription medicine decision summary (1)
Section 14, TGO91 consent (1)

Date

2026 (11)
2025 (16)
2024 (26)
2023 (23)
2022 (32)
2021 (15)
2020 (19)
2019 (24)
2018 (33)
2017 (17)
2016 (14)
2015 (10)
2014 (7)
2013 (13)
2012 (12)
2011 (17)
2010 (1)
2009 (6)
2008 (6)
2007 (13)
2006 (1)
2004 (2)
2001 (3)

Search

Sponsor content

321 result(s) found, displaying 11 to 20

OLANZAPINE GH IM (Generic Health Pty Ltd)

9 February 2026

Prescription medicine registration

Active ingredients: olanzapine.
SACUBITRIL/VALSARTAN LUPIN 24/26 sacubitril/valsartan (combined as a sodium salt complex) 24.3 mg/25.7 mg film-coated tablet blister pack (456091)

8 September 2025

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SACUBITRIL/VALSARTAN LUPIN 24/26 sacubitril/valsartan (combined as a sodium salt complex) 24.3 mg/25.7 mg film-coated tablet blister pack.
SACUBITRIL/VALSARTAN LUPIN 49/51 sacubitril/valsartan (combined as a sodium salt complex) 48.6 mg/51.4 mg film-coated tablet blister pack (456092)

8 September 2025

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SACUBITRIL/VALSARTAN LUPIN 49/51 sacubitril/valsartan (combined as a sodium salt complex) 48.6 mg/51.4 mg film-coated tablet blister pack.
SACUBITRIL/VALSARTAN LUPIN 97/103 sacubitril/valsartan (combined as a sodium salt complex) 97.2 mg/102.8 mg film-coated tablet blister pack (456093)

8 September 2025

ARTG

Australian Register of Therapeutic Goods (ARTG) information for SACUBITRIL/VALSARTAN LUPIN 97/103 sacubitril/valsartan (combined as a sodium salt complex) 97.2 mg/102.8 mg film-coated tablet blister pack.
Pharmacy Action Laxative with Senna Cancelled under Section 30(1)(c) of the Act

26 June 2025

Cancellation by sponsor

Requested by Generic Health Pty Ltd
Pharmacy Action Magnesium 500 mg Cancelled under Section 30(1)(c) of the Act

26 June 2025

Cancellation by sponsor

Requested by Generic Health Pty Ltd
RISPERIDONE GENERICHEALTH risperidone 1 mg/mL oral liquid solution bottle Cancelled under Section 30(1)(c) of the Act

26 June 2025

Cancellation by sponsor

Requested by Generic Health Pty Ltd
RIZATRIPTAN ODT GH rizatriptan (as benzoate) 5 mg orally disintegrating tablet blister pack Cancelled under Section 30(1)(c) of the Act

26 June 2025

Cancellation by sponsor

Requested by Generic Health Pty Ltd
RIZATRIPTAN ODT GH rizatriptan (as benzoate) 10 mg orally disintegrating tablet blister pack Cancelled under Section 30(1)(c) of the Act

26 June 2025

Cancellation by sponsor

Requested by Generic Health Pty Ltd
BETAHISTINE GH betahistine dihydrochloride 16 mg tablets blister packs Cancelled under Section 30(1)(c) of the Act

26 June 2025

Cancellation by sponsor

Requested by Generic Health Pty Ltd

Pages

First page
Previous page
Page 1
Current page 2
Page 3
Page 4
Page 5
Page 6
Page 7
Page 8
Page 9
…
Next page
Last page

Using our website

Accessibility
Privacy
Security
Disclaimer
Copyright
Freedom of information
Acronyms and glossary terms

Quick links

Search our databases
Report a problem or side effect
TGA Business Services
Special Access Scheme
Authorised Prescriber
Office of Drug Control
State and territory contacts

Connect with us

Email subscriptions
Contact us
Facebook
(formerly Twitter)
Youtube
Instagram
LinkedIn

Help us improve

We are always looking for ways to improve our website.

Provide feedback

The Department of Health, Disability and Ageing acknowledges First Nations peoples as the Traditional Owners of Country throughout Australia, and their continuing connection to land, sea and community. We pay our respects to them and their cultures, and to all Elders both past and present.